← FDA DRUG APPROVALS

FDA ANDA · ANDA074254

DESONIDE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA074254
TYPE
ANDA
ORIGINAL APPROVAL
1994-08-03
LATEST ACTION
2016-01-15
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

DESONIDEPrescription
DESONIDE 0.05% · OINTMENT · TOPICAL

Approval history

2016-01-15Labeling · Supplement 10 · standardAP
1998-01-20Manufacturing (CMC) · Supplement 3AP
1997-08-11Manufacturing (CMC) · Supplement 2AP
1996-09-17Manufacturing (CMC) · Supplement 1AP
1994-08-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →